Medifast MED Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $346.1M-36.3% | $385.79M-36.0% | $429.7M-36.3% | $480.45M-37.6% | $543.45M-39.5% | ||
| $103.41M-27.1% | $110.6M-29.9% | $118.43M-33.0% | $125.67M-37.4% | $141.88M-41.1% | ||
| $242.7M-39.6% | $275.19M-38.1% | $311.27M-37.5% | $354.78M-37.7% | $401.58M-38.9% | ||
| 70.1%-3.8pp | 71.3%-2.5pp | 72.4%-1.4pp | 73.8%-0.1pp | 73.9%+0.7pp | ||
| $258.94M-36.5% | $289.4M-34.5% | $316.97M-34.9% | $354.3M-33.8% | $407.9M-29.2% | ||
| $14.45M+13.5% | $14.24M+12.1% | $13.96M+8.4% | $13.7M+4.7% | $12.73M-5.0% | ||
| -$16.25M-157% | -$14.21M-594% | -$5.7M-153% | $487K-98.6% | -$6.32M-108% | ||
| -4.7%-3.5pp | -3.7%-4.2pp | -1.3%-2.9pp | 0.1%-4.3pp | -1.2%-10.2pp | ||
| —— | —— | —— | —— | —— | ||
| $8.14M+959% | $8.57M+843% | $7.72M+425% | $5.77M+89.9% | -$948K-115% | ||
| -$8.11M-11.5% | -$5.64M-249% | $2.02M-83.6% | $6.25M-83.2% | -$7.27M-108% | ||
| $11.92M+4,433% | $13.03M+669% | $1.77M-64.5% | $2.62M-67.1% | -$275K-101% | ||
| -$20.02M-186% | -$18.67M-993% | $248K-96.6% | $3.64M-87.6% | -$7M-110% | ||
| -5.8%-4.5pp | -4.8%-5.2pp | 0.1%-1.0pp | 0.8%-3.1pp | -1.3%-8.8pp | ||
| -$1.83-182% | -$1.71-1,050% | $0.01-98.5% | $0.32-88.1% | -$0.65-110% | ||
| -$1.82-180% | -$1.70-1,044% | $0.02-97.0% | $0.33-87.7% | -$0.65-110% | ||
| 44M+0.5% | 44M+0.3% | 44M+0.4% | 43.9M+0.4% | 43.8M+0.2% | ||
| 44M+0.5% | 43.9M+0.5% | 43.9M+0.4% | 43.8M+0.4% | 43.8M+0.4% | ||
| -$669K+88.7% | $17K+100% | -$341K+90.8% | -$2.34M-39.4% | -$5.91M-332% | ||
| $11.44M+253% | $11.46M+255% | -$8.17M-220% | -$7.41M-1,865% | -$7.5M-1,533% | ||
| -$1.05M-127% | -$1.37M-1,443% | -$1.04M-72.9% | -$433K+28.3% | -$463K+60.9% | ||
| —— | —— | —— | —— | —— | ||
| -$19.37M+22.8% | -$23.91M+31.7% | -$30.83M-27.7% | -$34.66M-48.8% | -$25.07M+15.7% | ||
| -$8.16M-201% | -$6.81M-167% | $3.72M+139% | $4.22M— | $8.1M— | ||
| -$17.96M— | -$22.19M— | —— | —— | —— | ||
| $1.89M+672% | $2.2M+655% | -$150K-283% | $118K-95.0% | -$331K-109% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | -$569K+98.5% | -$587K+98.9% | ||
| -$23.01M+10.8% | -$7.93M+70.1% | -$22.41M-25.8% | -$9.91M+84.1% | -$25.8M+58.2% | ||
| —— | —— | —— | —— | —— | ||
| $2.55M+144% | $3.06M+178% | $2.67M+175% | $811K+148% | -$5.83M-350% | ||
| —— | —— | —— | $196K-99.5% | $199K-99.6% | ||
| $118.74M+127% | $84.41M+81.2% | $73.74M+87.5% | $60.01M-22.5% | $52.42M-24.0% | ||
| $5.19M-27.3% | $5.61M-24.7% | $6.55M+7.1% | $6.58M+2.7% | $7.14M+14.9% | ||
| $97.28M+188% | $82.09M+198% | $57.88M+110% | $56.68M+166% | $33.75M+151% | ||
| $346.1M-36.3% | $385.79M-36.0% | $429.7M-36.3% | $480.45M-37.6% | $543.45M-39.5% | ||
| $7.61M+6.8% | $7.64M+3.7% | $7.6M-0.3% | $7.3M-24.7% | $7.12M-27.0% | ||
| -$16.25M-157% | -$14.21M-594% | -$5.7M-153% | $487K-98.6% | -$6.32M-108% | ||
| -$1.8M-128% | $30K-99.8% | $8.26M-65.2% | $14.19M-70.0% | $6.4M-93.2% | ||
| -$1.8M-128% | $30K-99.8% | $8.26M-65.2% | $14.19M-70.0% | $6.4M-93.2% | ||
| -0.5%-1.7pp | 0%-2.6pp | 1.9%-1.6pp | 3%-3.2pp | 1.2%-9.3pp | ||
| -$16.25M-157% | -$14.21M-594% | -$5.7M-153% | $487K-98.6% | -$6.32M-108% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Medifast's revenue?
- Medifast (MED) generated $346.1M in revenue over the trailing twelve months, down 36.3% year over year.
- Is Medifast profitable?
- Medifast is not currently profitable: it reported a net loss of $20.0M over the trailing twelve months, a -5.8% net margin.
- What are Medifast's profit margins?
- Gross margin is 70.1% and operating margin is -4.7%, with a -5.8% net margin.
- What is Medifast's earnings per share?
- Medifast's diluted EPS over the trailing twelve months is $-1.83.
- Where does Medifast's income statement data come from?
- Every line is extracted from Medifast's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
